TÜBA Associate Member Prof. Dr. Türker Kılıç Has Been Chosen by the European Sciences and Arts Academy
TÜBA Associate Member, Bahçeşehir Üniversitesi Medical Faculty Founder and Dean MedicalPark Hastaneler Grubu Neurosciences Academy Founder, Brain Surgery Department Head Prof. Dr. Türker Kılıç, has been chosen to become a member of one of the world’s most reputable academies, the European Sciences and Arts Academy (Academia Scientiarum et Artium Europaea).
Bahçeşehir University Medical Faculty Dean Prof. Dr. Türker Kılıç, who is known for his innovative studies on “Brain Surgery and Brain Tumors”, has taken his place as the 10th Turk in the Academy with the work he has done in the fields of cerebrovascular diseases and brain tumors. Prof. Dr. Türker is now one of the three names in addition to Prof. Dr. Turgay Dalkara and Prof. Dr. Taner Demirer, who are also Tüba members, that are now members of the European Sciences and Arts Academy.
The European Sciences and Arts Academy Human Sciences, which also includes scientists who have contributed to a number of different sciences, artists who have given direction to art, theologians, legal experts and economists supports work in the fields of Medicine, Art, Natural Sciences, Social Sciences, Law, Economy, Technical/Natural Sciences, Environmental Sciences and World Religions. With nearly 1500 members, 30 of which are Nobel Prize recipients, the European Sciences and Arts Academy has achievements in fields that are especially relevant to Europe and scientific and cultural fields that benefit humanity. Some of the existing members also include select scientists from Asia and the U.S. The academy, which has the advantage of examining issues from different points of view and finding solutions through its diversity of scientists and artists, creates a common pool of knowledge, dialogue among disciplines and unites under a theme in which different ideas and thoughts are brought together to form an international scientific discourse. Among the projects and studies conducted by the academy, which has an international and interdisciplinary structure, are “Health in Regions”, “Danube Rectors’ Conference” and the integrating and reciprocally balancing “Danube Academies Conference”, “Interreligious Dialogues” and “Tolerance Charta”, “Manifest of Freedom of Sciences” and “Manifest for Europe”.
In the framework of the above mentioned mission by the “European Sciences and Arts Academy”, Prof. Dr. Türker Kılıç’s scientific studies won the “Most Valuable Research Award” at the European Association of Neurosurgical Societies (EANS) in 1999 and the “Neuro-Oncology Young Researcher Award” in 2001 at the American Association of Neurological Surgeons (AANS).
His scientific studies won the American Association of Neurological Surgeons (AANS) “Most Valuable Scientific Study Outside of the US Award” in 2005. Prof. Dr. Kılıç, worked in the years 1997-1998 at the Harvard University on the astrocytomas that are brain tumors and worked as the researcher in charge of proving the effect of a molecule in astrocytomas, a project he is currently still working on. When this study was published in the year 2000 NIH approval was obtained and as a result of clinical studies, a molecule that had been worked on was made into a drug (Glivec) and is now currently being used in the treatment of some types of brain cancer.
The Molecular Laboratory neurosurgery, which he is still conducting, has won grants and R&D support from over 20 different companies. In the laboratory which contains a tumor bank of nearly 3000 preserved tissue samples, national and international joint projects are being conducted in the fields of cerebrovascular diseases and neuro-oncology.
Dr. Kılıç, whose H index on the scientific value scale is 22, continues to research brain tumors and the molecular pathogenesis of vascular diseases and has over 1800 references to his work in science.
Also the founding dean of the BAU TIP, which aims to raise scientists and physicians, Prof Kılıç says that his goal is to create a new generation of scientists and physicians in this medical faculty, who can show the courage to work and live as individuals with the scientific quality and quantity that surpass him and his generation to become the candidates for future Nobel prizes.